The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism

Viruses

Volumn 11, Issue 10, 2019, Pages

  Cheng, Jinlong ^a   Zhao, Ye ^a   Xu, Gang ^a   Zhang, Keran ^a   Jia, Wenfeng ^a   Sun, Yali ^a   Zhao, Jing ^a   Xue, Jia ^a   Hu, Yanxin ^a   Zhang, Guozhong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Coronavirus; Encephalitis; Furin S2' site; Infectious bronchitis virus; Neurotropism; QXtype

Indexed keywords

VIRUS SPIKE PROTEIN; CORONAVIRUS SPIKE GLYCOPROTEIN; FURIN; VIRUS ANTIBODY;

ANIMAL TISSUE; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; BRAIN TISSUE; CHICKEN; CONTROLLED STUDY; CORONAVIRINAE; ELECTROPORATION; EMBRYO; GENOME; GENOTYPE; GROWTH CURVE; HISTOPATHOLOGY; HYPERPLASIA; ID50; IMMUNOHISTOCHEMISTRY; KIDNEY INTERSTITIUM; MICROGLIA; NEUROTROPISM; NONHUMAN; PATHOGENICITY; TRACHEA TISSUE; VIRUS RECOMBINANT; ANIMAL; BLOOD; BLOOD BRAIN BARRIER; CHEMISTRY; CORONAVIRUS INFECTION; GENETICS; GERMFREE ANIMAL; MUTATION; NERVE CELL; PHYSIOLOGY; VETERINARY MEDICINE; VIRAL TROPISM; VIROLOGY; VIRUS ENCEPHALITIS;

ANIMALS; ANTIBODIES, VIRAL; BLOOD-BRAIN BARRIER; CHICKENS; CORONAVIRUS INFECTIONS; ENCEPHALITIS, VIRAL; FURIN; INFECTIOUS BRONCHITIS VIRUS; MUTATION; NEURONS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPIKE GLYCOPROTEIN, CORONAVIRUS; VIRAL TROPISM;

EID: 85074140882     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v11100972     Document Type: Article

References (36)

1. Woo, P.C.Y.; Lau, S.K.P.; Huang, Y.; Yuen, K.Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp. Biol. Med. 2009, 234, 1117-1127. [CrossRef]
2. Jackwood, M.W. Review of infectious bronchitis virus around the world. Avian Dis. 2012, 56, 634-641. [CrossRef]
3. Bertram, S.; Dijkman, R.; Habjan, M.; Heurich, A.; Gierer, S.; Glowacka, I.; Welsch, K.; Winkler, M.; Schneider, H.; Hofmann-Winkler, H.; et al. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J. Virol. 2013, 87, 6150-6160. [CrossRef]
4. Peiris, J.S.; Lai, S.T.; Poon, L.L.; Guan, Y.; Yam, L.Y.; Lim, W.; Nicholls, J.; Yee, W.K.; Yan, W.W.; Cheung, M.T.; et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361, 1319-1325. [CrossRef]
5. Zaki, A.M.; van Boheemen, S.; Bestebroer, T.M.; Osterhaus, A.D.M.E.; Fouchier, R.A.M. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367, 1814-1820. [CrossRef] [PubMed]
6. Sun, N.; Grzybicki, D.; Castro, R.F.; Murphy, S.; Perlman, S. Activation of Astrocytes in the Spinal Cord of Mice Chronically Infected with a Neurotropic Coronavirus. Virology 1995, 213, 482-493. [CrossRef] [PubMed]
7. Bergmann, C.C.; Lane, T.E.; Stohlman, S.A. Coronavirus infection of the central nervous system: Host-virus stand-o. Nat. Rev. Microbiol. 2006, 4, 121-132. [CrossRef] [PubMed]
8. Arbour, N.; Côté, G.; Lachance, C.; Tardieu, M.; Cashman, N.R.; Talbot, P.J. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J. Virol. 1999, 73, 3338-3350. [PubMed]
9. St-Jean, J.R.; Jacomy, H.; Desforges, M.; Vabret, A.; Freymuth, F.; Talbot, P.J. Human respiratory coronavirus OC43: Genetic stability and neuroinvasion. J. Virol. 2004, 78, 8824-8834. [CrossRef]
10. Jacomy, H.; Fragoso, G.; Almazan, G.; Mushynski, W.E.; Talbot, P.J. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology 2006, 349, 335-346. [CrossRef]
11. Arbour, N.; Day, R.; Newcombe, J.; Talbot, P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2002, 74, 8913-8921. [CrossRef] [PubMed]
12. Tecchio, C.; Micheletti, A.; Cassatella, M.A. Neutrophil-derived cytokines: Facts beyond expression. Front. Immunol. 2014, 5, 508. [CrossRef] [PubMed]
13. Cheng, J.; Huo, C.; Zhao, J.; Liu, T.; Li, X.; Yan, S. Pathogenicity differences between QX-like and Mass-type infectious bronchitis viruses. Vet. Microbiol. 2018, 213, 129-135. [CrossRef]
14. Yan, S.; Liu, X.; Zhao, J.; Xu, G.; Zhao, Y.; Zhang, G. Analysis of antigenicity and pathogenicity reveals major differences among QX-like infectious bronchitis viruses and other serotypes. Vet. Microbiol. 2017, 203, 167-173. [CrossRef] [PubMed]
15. Xu, G.; Cheng, J.; Ma, S.; Jia, W.; Yan, S.; Zhang, G. Pathogenicity differences between a newly emerged TW-like strain and a prevalent QX-like strain of infectious bronchitis virus. Vet. Microbiol. 2016, 227, 20-28. [CrossRef]
16. Zhong, Q.; Hu, Y.X.; Jin, J.H.; Zhao, Y.; Zhao, J.; Zhang, G.Z. Pathogenicity of virulent infectious bronchitis virus isolate YN on hen ovary and oviduct. Vet. Microbiol. 2016, 193, 100-105. [CrossRef]
17. Masters, P.S. The molecular biology of coronaviruses. Adv. Virus Res. 2006, 65, 193-292.
18. de Haan, C.A.M.; Rottier, P.J.M. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 2005, 64, 165-230.
19. Bosch, B.J.; van der Zee, R.; de Haan, C.A.M.; Rottier, P.J.M. The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J. Virol. 2003, 77, 8801-8811. [CrossRef]
20. Maier, H.J.; Bickerton, E.; Britton, P. Coronaviruses: Methods and Protocols; Humana Press: Totowa, NJ, USA, 2015.
21. Bosch, B.J.; Bartelink, W.; Rottier, P.J.M. Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J. Virol. 2008, 82, 8887-8890. [CrossRef]
22. Burkard, C.; Verheije, M.H.; Wicht, O.; van Kasteren, S.I.; van Kuppeveld, F.J.; Haagmans, B.L.; Pelkmans, L.; Rottier, P.J.; Bosch, B.J.; de Haan, C.A. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog. 2014, 10, e1004502. [CrossRef] [PubMed]
23. Alonso-Caplen, F.V.; Matsuoka, Y.;Wilcox, G.E.; Compans, R.W. Replication and morphogenesis of avian coronavirus in Vero cells and their inhibition by monensin. Virus Res. 1984, 1, 153-167. [CrossRef]
24. Stevenson-Leggett, P.; Bickerton, E.; Britton, P.; Armesto, M.; Maier, H.J. The S2 subunit of infectious bronchitis virus beaudette is a determinant of cellular tropism. J. Virol. 2018, 92, e01044.
25. Bickerton, E.; Dowgier, G.; Britton, P. Recombinant infectious bronchitis viruses expressing heterologous S1 subunits: Potential for a new generation of vaccines that replicate in Vero cells. J. Gen. Virol. 2018, 99, 1681-1685. [CrossRef] [PubMed]
26. Feng, J.; Hu, Y.; Ma, Z.; Yu, Q.; Zhao, J.; Liu, X.; Zhang, G. Virulent avian infectious bronchitis virus, People's Republic of China. Emerg. Infect. Dis. 2012, 18, 1994-2001. [CrossRef] [PubMed]
27. Yan, S.; Zhao, J.; Xie, D.; Huang, X.; Cheng, J.; Guo, Y.; Liu, C.; Ma, Z.; Yang, H.; Zhang, G. Attenuation, safety, and efficacy of a QX-like infectious bronchitis virus serotype vaccine. Vaccine 2018, 36, 1880-1886. [CrossRef]
28. Casais, R.; Thiel, V.; Siddell, S.G.; Cavanagh, D.; Britton, P. Reverse genetics system for the avian coronavirus infectious bronchitis virus reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol. 2001, 75, 12359-12369. [CrossRef]
29. Reed, L.J.; Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 1938, 27, 493-497. [CrossRef]
30. Zhao, Y.; Cheng, J.L.; Liu, X.Y.; Zhao, J.; Hu, Y.X.; Zhang, G.Z. Safety and efficacy of an attenuated Chinese QX-like infectious bronchitis virus strain as a candidate vaccine. Vet. Microbiol. 2015, 180, 49-58. [CrossRef]
31. Kawase, M.; Shirato, K.; Matsuyama, S.; Taguchi, F. Protease-mediated entry via the endosome of human coronavirus 229E. J. Virol. 2008, 83, 712-721. [CrossRef]
32. Lane, T.E.; Asensio, V.C.; Yu, N.; Paoletti, A.D.; Campbell, I.L.; Buchmeier, M.J. Dynamic regulation of alpha-and beta-chemokine ex-pression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol. 1998, 160, 970-978. [PubMed]
33. Hosking, M.P.; Liu, L.; Ransoho, R.M.; Lane, T.E. A protective role for ELR+ chemokines during acute viral encephalomyelitis. PLoS Pathog. 2009, 5, e1000648. [CrossRef] [PubMed]
34. Le Coupanec, A.; Desforges, M.; Meessen-Pinard, M.; Dubé, M.; Day, R.; Seidah, N.G.; Talbot, P.J. Cleavage of a neuroinvasive human respiratory virus spike glycoprotein by proprotein convertases modulates neurovirulence and virus spread within the central nervous system. PLoS Pathog. 2015, 11, e1005261. [CrossRef]
35. Jacomy, H.; St-Jean, J.R.; Brison, E.; Marceau, G.; Desforges, M.; Talbot, P.J. Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB/c mice from encephalitis to flaccid paralysis and demyelination. J. Neurovirol. 2010, 16, 279-293. [CrossRef]
36. Shang, J.; Zheng, Y.; Yang, Y.; Liu, C.; Geng, Q.; Luo, C.; Zhang,W.; Li, F. Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins. PLoS Pathog. 2018, 14, e1007009. [CrossRef]